United-Guardian Q2 net sales fall 16% YoY; EPS $0.14 vs $0.21

UNITED GUARDIAN INC

Q2 net sales $2.84M, down 16% YoY from $3.39M; net income $627K ($0.14) vs $956K ($0.21).
H1 net sales $5.32M, down 20% YoY; net income $1.19M ($0.26) vs $1.88M ($0.41).
Medical lubricants +12% and pharmaceuticals +11% in H1; cosmetic sales fell due to ASI inventory overstock in Asia.
Q2 sequential improvement: sales +14% and net income +12% vs Q1 2025.
Company pursuing Renacidin formulary expansion to boost pharmaceutical sales.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.